Dr. Daniel King,

Dr. King has been practicing as an orthopedist in Brevard County for almost 30 years. He specializes in the surgical and non-surgical treatment of hips, knees, and shoulders. Dr. King’s approach to total joint care is unrivaled. He takes the patient’s whole situation into consideration, weighing all the options before making recommendations as to course of action.

Curriculum Vitae

Practice Experience

July 2001 to Present Arthritis and Joint Center of Florida
Melbourne, Florida
1985 to July 2001 Brevard Orthopaedic Clinic
Melbourne, Florida

Practice Specialty

Adult Reconstructive Surgery including joint replacement and arthroscopic surgery.

Medical Licensure

Licensed by the State of Florida since October, 1982

Board Certification

American Board of Orthopaedic Surgery
Certified July 1987
Re-certified October 1996

Re-certified  April 2017

Hospital Privileges

Health First Holmes Regional Medical Center
1985 to Present Active Staff
1990 to 1993 Chairman Department of Orthopaedics
1998 to 1999 President of Medical Staff
1998 to 1999 Board Member HRMC

Wuesthoff Hospital Melbourne
Active Staff

Memberships

Brevard County Medical Society
American Academy of Orthopedic Surgerons
Florida Orthopaedic Society

Honors

Alpha Omega Alpha, Medical Honorary Society 1980

Education

1999 Florida Institute of Technology
Melbourne, Florida
Masters of Business Administration

1985 University of South Florida affiliated hospitals, Tampa. Florida
Resident in Orthopaedic Surgery
Specialty training in Adult Reconstruction, Kenneth Gustke, M.D.
Trauma Orthopaedics, Jeffrey Mast, M.D.
Program Chairman, Philip Spiegel, M.D.

1980 University of South Florida College of Medicine,
Tampa, Florida
Doctor of Medicine

1976 University of Florida, Gainesville, Florida
Bachelor of Science, Zoology

Clinical Research

Orthobiotech, Inc. (Procrit Vigor Study), Protocol pr99-19-019
“Clinical Evaluation of Perioperative Hemoglobin and the Relationship to Postoperative Vigor in Patients undergoing Total Joint Arthroplasty”
1/19/1999 – 10/19/2000

Sanofi (Pentasaccharide Study), Protocol EFC 2442
“A Multi Center, Multinational, Double-Bind Comparison of Subcutaneous SR90107A/Org31540 with Enoxaparin in the Prevention of Deep Vein Thrombosis and Symptomatic Pulmonary Embolism after Elective Hip Replacement” 4/22/1999 – 11/10/1999

Emisphere Technology/Auintiles, (Oral Heparin Study) “The Protect Trial”, Protocol ERP 12/3 to ERP 12/4
“A Radomized, Double-Blind, Multi Center Study Comparing the Safety and Efficacy of Two Dosing Regimens of Oral Emisphere SNAC/Heparin with Subcutaneous Enoxaparin Sodium for the Presentation of Venous Thromboembolic Events” 1/15/2000 – 11/16/2000

Prospective, Randomized, FDA approved, Metal Bearing Total Hip, Implex Corporation, Protocol IC001-99
“Performance of the Implex Hedocel Metal Bearing Total Hip Replacement System in Primary Total Hip Arthroplasty” 10/1999 - Present

Prospective, Consecutive, Total Knee Outcomes Study, Utilizing Hedrocel Mono block Tibia, Implex Corporation, 6/2000 - Present